Expansion Milestones Omada’s Nasdaq listing and planned leadership transition signal a growth trajectory and renewed strategy. This presents an opportunity to position scalable virtual care and chronic-condition programs to institutional buyers seeking proven ROI and publicly verifiable performance as the company scales.

Financial Strength With 250M to 500M in revenue and 529M in funding, Omada demonstrates substantial financial resources and investor backing. This supports deeper contracts, multi-year deployments with employers and health plans, and potential upsell of advanced programs or GLP-1 journey capabilities.

Employer and Plan Focus Omada already partners with employers, health plans, PBMs, and government agencies. There is a clear path to expand into additional large employer cohorts, new plan designs, or benefit structures that reward chronic disease management and reduced costs, leveraging their peer-reviewed outcomes.

Clinical Validation Publications across 30 peer-reviewed studies showcasing behavior change, cost reductions, and ROI create a strong case for procurement pitches. Use these validated outcomes to target health plans and self-insured employers seeking measurable value and risk reduction.

Leadership Continuity Executive transitions with a new CEO and ongoing founder-aligned governance suggest stability and a fresh go-to-market approach. Position Omada as a trusted partner during leadership change, offering scalable digital health platforms and customer success models aligned with enterprise needs.